2.64
7.76%
0.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché IBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.45
Aprire:
$2.46
Volume 24 ore:
307.26K
Relative Volume:
2.46
Capitalizzazione di mercato:
$24.15M
Reddito:
$2.05M
Utile/perdita netta:
$-27.28M
Rapporto P/E:
-0.4583
EPS:
-5.76
Flusso di cassa netto:
$-18.89M
1 W Prestazione:
+15.79%
1M Prestazione:
-8.65%
6M Prestazione:
+17.33%
1 anno Prestazione:
+896.23%
iBio Inc Stock (IBIO) Company Profile
Nome
iBio Inc
Settore
Industria
Telefono
302-355-0650
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Confronta IBIO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
IBIO | 2.64 | 24.15M | 2.05M | -27.28M | -18.89M | -5.76 |
VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-11-29 | Iniziato | JMP Securities | Mkt Outperform |
2021-01-22 | Iniziato | Cantor Fitzgerald | Overweight |
2020-06-26 | Iniziato | Alliance Global Partners | Buy |
iBio Inc Borsa (IBIO) Ultime notizie
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com
ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire
iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World
iBio Inc. stock remains steady Monday, underperforms market - MarketWatch
iBio Inc. stock rises Monday, outperforms market - MarketWatch
iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks
Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR
iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, underperforms market - MarketWatch
Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments - GlobeNewswire Inc.
Lead molecule identified under Ibio and Astralbio’s myostatin program for obesity - BioWorld Online
Items Tagged with 'Astralbio Inc.' - BioWorld Online
iBio and AstralBio Provide Update on Myostatin Program for Obesity - GlobeNewswire
IBio, Inc. and AstralBio Provide Update on Myostatin Program for Obesity - Marketscreener.com
IBIO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
What is going on with iBio Inc? Sentiment Analysis - US Post News
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio (NYSE:IBIO) Trading 1.6% Higher - Defense World
Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha
Biafra: Why We Ended Nnamdi Kanu’s Trial – Lawyer Ejimakor - Tori.ng
Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex
iBio Inc Azioni (IBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):